Biovitrum AB Acquires The Pharmaceutical Company Arexis AB 
10/19/2005 5:08:44 PM

STOCKHOLM, Sweden, Aug. 22, 2005 (PRIMEZONE) -- Biovitrum expands the project portfolio with projects in clinical phase, both I and II, together with additional preclinical projects within its prioritised therapeutic areas by the acquisition of Arexis, a company that develops pharmaceuticals for the treatment of metabolic and inflammatory diseases.